BACKGROUND
Uncertainty persists regarding the effects of intensive blood-pressure lowering in patients with type 2 diabetes.
METHODS
In this multicenter, open-label, randomized trial conducted in Brazil, patients with elevated blood pressure, type 2 diabetes, and high cardiovascular risk received intensive therapy ta...
K. Santo, E. Martins, Gisele S. Silva et al.· New England Journal of Medic...· 0 citations
BACKGROUND
Whether intensive blood-pressure control reduces cardiovascular risk after cerebrovascular events remains uncertain.
METHODS
In this multicenter, open-label, randomized trial conducted at 30 sites in Brazil, we assigned participants with elevated blood pressure and previous ischemic stroke or transient isc...
G. Silva, M. J. Machline-Carrion, K. Santo et al.· New England Journal of Medic...· 0 citations
Few data are available on platelet reactivity in patients exposed to potent P2Y12 inhibitor monotherapy without aspirin.
This study was nested within the NEO-MINDSET trial, a multicenter, randomised trial evaluating potent P2Y12 inhibitor monotherapy early after percutaneous coronary intervention (PCI) for...
P. Guimaraes, T. P. Oliveira, M. Franken et al.· European Heart Journal· 0 citations
The OPTIMAL-STROKE trial will be the first adequately powered trial of intensive BP control in the prevention of major cardiovascular events in patients with a history of ischaemic stroke or TIA.
Gisele S. Silva, M. J. Machline-Carrion, K. Santo et al.· European Stroke Journal· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.